Psychemedics Statistics
Total Valuation
Psychemedics has a market cap or net worth of 11.08 million. The enterprise value is 11.26 million.
| Market Cap | 11.08M |
| Enterprise Value | 11.26M |
Important Dates
The next estimated earnings date is Thursday, April 3, 2025.
| Earnings Date | Apr 3, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Psychemedics has 5.89 million shares outstanding. The number of shares has increased by 2.05% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 5.89M |
| Shares Change (YoY) | +2.05% |
| Shares Change (QoQ) | +1.32% |
| Owned by Insiders (%) | 26.77% |
| Owned by Institutions (%) | 20.94% |
| Float | 2.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.54 |
| PB Ratio | 2.04 |
| P/TBV Ratio | 2.03 |
| P/FCF Ratio | 22.48 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.76 |
| EV / Sales | 0.56 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 22.83 |
Financial Position
The company has a current ratio of 1.59, with a Debt / Equity ratio of 0.29.
| Current Ratio | 1.59 |
| Quick Ratio | 1.25 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | n/a |
| Debt / FCF | 3.20 |
| Interest Coverage | -86.15 |
Financial Efficiency
Return on equity (ROE) is -46.52% and return on invested capital (ROIC) is -21.41%.
| Return on Equity (ROE) | -46.52% |
| Return on Assets (ROA) | -15.29% |
| Return on Capital (ROIC) | -21.41% |
| Revenue Per Employee | 174,638 |
| Profits Per Employee | -25,819 |
| Employee Count | 116 |
| Asset Turnover | 1.69 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 0.67 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 127,715 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.89 |
Income Statement
In the last 12 months, Psychemedics had revenue of 20.26 million and -3.00 million in losses. Loss per share was -0.51.
| Revenue | 20.26M |
| Gross Profit | 7.77M |
| Operating Income | -2.93M |
| Pretax Income | -2.95M |
| Net Income | -3.00M |
| EBITDA | -1.89M |
| EBIT | -2.93M |
| Loss Per Share | -0.51 |
Balance Sheet
The company has 1.41 million in cash and 1.58 million in debt, giving a net cash position of -174,000 or -0.03 per share.
| Cash & Cash Equivalents | 1.41M |
| Total Debt | 1.58M |
| Net Cash | -174,000 |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | 5.45M |
| Book Value Per Share | 0.92 |
| Working Capital | 2.25M |
Cash Flow
In the last 12 months, operating cash flow was 572,000 and capital expenditures -79,000, giving a free cash flow of 493,000.
| Operating Cash Flow | 572,000 |
| Capital Expenditures | -79,000 |
| Free Cash Flow | 493,000 |
| FCF Per Share | 0.08 |
Margins
Gross margin is 38.36%, with operating and profit margins of -14.46% and -14.78%.
| Gross Margin | 38.36% |
| Operating Margin | -14.46% |
| Pretax Margin | -14.57% |
| Profit Margin | -14.78% |
| EBITDA Margin | -9.31% |
| EBIT Margin | -14.46% |
| FCF Margin | 2.43% |
Dividends & Yields
Psychemedics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.05% |
| Shareholder Yield | -2.05% |
| Earnings Yield | -27.36% |
| FCF Yield | 4.45% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | Dec 4, 2024 |
| Split Type | n/a |
| Split Ratio | 1 |
Scores
Psychemedics has an Altman Z-Score of 0.77. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.77 |
| Piotroski F-Score | n/a |